Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GLAXOSMITHKLINE SA

Home Clinical Trial Sponsors and OrganizationsGLAXOSMITHKLINE SA

GLAXOSMITHKLINE SA

CALLE DE SEVERO OCHOA (- PQ TECNOLOGICO DE MADRID) 2, Tres Cantos, Madrid, Spain

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

230

230 active

Approvals

233

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

172

74.8%

Trial Status Distribution

Active, not recruiting

230

100.0%

Clinical Trials

Trials sponsored by this organization (230)

A study on the reactogenicity, safety, immune response, and efficacy of a vaccine against HSV-2 in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent HSV-2 genital herpes

Active, not recruiting

Apr 2022332 participants

Investigation of depemokimab (GSK3511294) in patients with chronic rhinosinusitus with nasal polyps (CRSwNP).

Active, not recruiting

Feb 2022250 participants

OPAL Master ProtocolPhase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of Treatments in Participants with Ovarian Cancer (OPAL).OPAL-Supplement CCohort C: Open-Label Phase 2, Randomized, Controlled Multicenter Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants with Homologous Recombination-Deficient Stage III/IV Ovarian Cancer.

Active, not recruiting

Dec 202184 participants

A study on the safety, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide against chronic Hepatitis B (CHB) and chronic Hepatitis B targeted immunotherapy (CHB-TI) in CHB patients receiving nucleos(t)ide analogue (NA) therapy.

Active, not recruiting

Nov 2021184 participants

A study to evaluate the safety and immune response to an unadjuvanted RSV maternal vaccine in healthy non-pregnant females from 9 to 49 years of age.

Active, not recruiting

Nov 2021252 participants

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants with Relapsed or Refractory Multiple Myeloma (DREAMM-14)

Active, not recruiting

Oct 2021102 participants

A study on the safety, tolerability and immune response of meningococcal combined ABCWY vaccine in healthy infants.

Active, not recruiting

Jul 2021688 participants

A Phase III study to assess the lot-to-lot consistency of GSK’s investigational RSV maternal vaccine and the immune response and safety of RSV maternal vaccine when given alone or co-administered with GSK’s influenza D-QIV vaccine in healthy non-pregnant women.

Active, not recruiting

Jun 20211,541 participants

Page 1 of 29

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

12

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

221

Approvals

Recent Approvals

SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Ropinirole Hydrochloride Sustained-release Tablets

Ropinirole Hydrochloride Sustained-release Tablets

FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

MENVEO SOLUCION INYECTABLE

ZEJULA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

News

No news articles found

On this page

Overview
Clinical Trials230
Approvals233
News

Back to Organizations